LORAZEPAM INJECTION USP
LORAZEPAM INJECTION USP
Approved
DIN Number
02243278
Drug Class
Human
Market Date
Jun 6, 2001
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243278
AIG Number0110731004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORAZEPAMActive
Strength: 4 MG / ML
Monograph: LORAZEPAM